Skip to search formSkip to main contentSkip to account menu

RU 29246

Known as: RU-29246, RU29246 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Cephalosporins

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1992
1992
In vitro activity of RU 29246, the active compound of the cephalosporin prodrug ester HR 916
The in vitro activity of RU 29246 was compared with those of other agents against 536 recent clinical isolates. The MICs of RU… 
1992
1992
Preliminary disk diffusion susceptibility testing criteria for cefdaloxime (RU29246, HR-916 metabolite), a new orally administered cephalosporin
Cefdaloxime (formerly RU29246; Hoechst-Roussel Pharmaceuticals Inc., Somerville, N.J.) a new active component of the HR-916 ester… 
1992
1992
Comparative in vitro activity and beta-lactamase stability of RU29246, the active metabolite of HR916B
HR 916B is a new orally absorbed cephalosporin. In tests its active metabolite, RU29246, inhibitedStreptococcus pyogenes… 
1991
1991
Quality control guidelines for Haemophilus test medium MIC susceptibility tests with cefmetazole, cefpodoxime, CI-960 (PD127391, AM-1090), and RU29246.
1991
1991
Antimicrobial activity of three investigational oral cephalosporins (BK-218, cefdinir, and RU29246) against Legionella.
1991
1991
In vitro activity of RU29246. The metabolite of a new HR916 cephalosporin ester.
1991
1991
Antimicrobial activity of RU29246 (HR916 metabolite) compared with four other oral beta-lactams tested against more than 5000 clinical isolates
The activity of RU29246, the active metabolite of the oral cephalosporin ester HR916, was compared in a multicenter study with… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)